Home » Tenders » Europe » Germany » Openhouse Procedure - Div. Active Ingredients from October 1St, 2022 Tender, Germany - 73118164

Openhouse Procedure - Div. Active Ingredients from October 1St, 2022 Tender, Germany - 73118164

Download Documents

AOK RHINELAND/HAMBURG - THE HEALTH INSURANCE FUND has floated a tender for Openhouse Procedure - Div. Active Ingredients from October 1St, 2022. The project location is Germany and the tender is closing on 31 Aug 2024. The tender notice number is 564051-2022, while the TOT Ref Number is 73118164. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Openhouse Procedure - Div. Active Ingredients from October 1St, 2022

Deadline : 31 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 73118164

Document Ref. No. : 564051-2022

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Conclusion of non-exclusive discount agreements according to § 130 a paragraph 8 SGB V with the possibility of conclusion at any time as part of the so-called "Open House procedure" for various active pharmaceutical ingredients with the earliest possible start of the contract on October 1st, 2022.

.

The specific active pharmaceutical ingredients and the respective VeContract starts can be found in the current list of active pharmaceutical ingredients in the project room of the procurement portal dtvp in the "Award documents" section.

.

As of October 1st, 2022, contracts for the following active ingredients will be offered:

.

Abacavir / lamivudine / zidovudine

Acetylcystein_non-RX non-RX

Acetylcystein_RX RX

Acetylsalicylic acid products that can only be prescribed according to Annex 1 AM-RL G-BA

Acitretin

Adefovir dipivoxil

Alitretinoin

Amifampridine

Anagrelide except N3 packs of the DAR HKP with 0.5 mg strength

Aripiprazole excluding DAR tablets/melt tablets and oral solutions

Atorvastatin/ezetimibe

beclometasone/formoterol

beclometasone/formoterol/glycopyrronium

bimatoprost

biperiden

bortezomib

brivudine

budesonide except inhalatives

calcipotriol

calcium / colecalciferol

ceftriaxone

clomipramine 75 mg strength, slow-release

clostridium botulinum except lifestyle drugs

colecalciferol non-RX

colecalciferol RX

colistin

cyproterone

deferasirox

desloratadin

desogestrel / ethinylestradiol

dienogest

dienogest / ethinylestradiol

diltiazem

distigmin

dornase alpha

dronedarone

drospirenone / ethinylestradiol

ebastine

iron II oral DAR/exclusively according to Appendix 1 AM-RL G-BA prescribe...
Document Type : Corrigendum/Additional information (Please refer tender document)
Reference Number : 2022-06 Abteilung Arzeimittel
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union, with participation by GPA countries
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2022-10-10
Publish Date : 2022-10-14
Submission Date : 2024-08-31